Edition:
United Kingdom

Regenxbio Inc (RGNX.OQ)

RGNX.OQ on NASDAQ Stock Exchange Global Select Market

59.04USD
23 Oct 2018
Change (% chg)

$0.38 (+0.65%)
Prev Close
$58.66
Open
$57.55
Day's High
$60.28
Day's Low
$55.66
Volume
130,773
Avg. Vol
188,106
52-wk High
$85.05
52-wk Low
$23.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 40.03 0.300
Mar '18 132.39 3.041
FY 2017 Dec '17 2.04 -0.513
Sep '17 1.34 -0.669
Jun '17 6.56 -0.472
Mar '17 0.46 -0.825
FY 2016 Dec '16 1.70 -0.741
Sep '16 0.12 -0.686
Jun '16 2.38 -0.548
Mar '16 0.39 -0.409
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 10.00 20.00 0.00 2.00
Quarter Ending Mar-19 1 0.64 0.64 0.64 --
Year Ending Dec-18 6 194.55 232.40 172.00 5.41
Year Ending Dec-19 6 13.59 18.84 6.00 10.00
Earnings (per share)
Quarter Ending Dec-18 2 -0.84 -0.80 -0.88 -0.69
Quarter Ending Mar-19 1 -1.28 -1.28 -1.28 --
Year Ending Dec-18 3 1.66 1.71 1.60 -2.95
Year Ending Dec-19 3 -4.03 -3.37 -4.77 -3.55
LT Growth Rate (%) 1 3.00 3.00 3.00 -9.50
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.35 33.64
P/E High - Last 5 Yrs. -- 287.14 45.18
P/E Low - Last 5 Yrs. -- 89.68 23.74
Beta -- 0.93 0.88
Price to Sales (TTM) 117.63 124.53 5.83
Price to Book (MRQ) 4.90 15.28 4.89
Price to Tangible Book (MRQ) 4.91 14.51 6.51
Price to Cash Flow (TTM) -- 70.04 22.92
% Owned Institutions 74.23 14.28 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.54 5.41
Payout Ratio(TTM) -- 16.74 43.84

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 176.29 411.24 8.09
Sales (TTM) vs TTM 1 Yr. Ago 5.77 103.59 5.81
Sales - 5 Yr. Growth Rate -- 30.71 9.88
EPS (MRQ) vs Qtr. 1 Yr. Ago 13.81 23.99 23.40
EPS (TTM) vs TTM 1 Yr. Ago -90.63 -- --
EPS - 5 Yr. Growth Rate -- 37.59 10.92
Capital Spending - 5 Yr. Growth Rate -- 38.51 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.95 2.25
Current Ratio (MRQ) 14.47 5.36 3.05
LT Debt to Equity (MRQ) 0.00 34.91 12.79
Total Debt to Equity (MRQ) 0.00 36.72 17.21
Interest Coverage (TTM) -- -97.07 37.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 79.94 40.06 54.86
Gross Margin - 5 Yr. Avg. -- 48.98 52.38
EBITD Margin (TTM) -852.14 -- --
EBITD - 5 Yr. Avg -- -578.76 11.01
Operating Margin (TTM) -872.54 -789.30 4.03
Operating Margin - 5 Yr. Avg. -- -599.86 6.34
Pre-Tax Margin (TTM) -844.80 -751.43 5.08
Pre-Tax Margin - 5 Yr. Avg. -- -605.48 6.78
Net Profit Margin (TTM) -839.87 -752.40 1.35
Net Profit Margin - 5 Yr. Avg. -- -608.15 3.03
Effective Tax Rate (TTM) -- 23.50 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.68 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 82,598 22,659,931 807,592,034
Net Income/Employee (TTM) -693,720 1,701,937 94,981,854
Receivable Turnover (TTM) 21.22 20.75 5.78
Inventory Turnover (TTM) -- 2.37 3.63
Asset Turnover (TTM) 0.04 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -34.49 -1.42 10.90
Return on Assets - 5 Yr. Avg. -- 3.03 12.01
Return on Investment (TTM) -36.22 0.18 14.27
Return on Investment - 5 Yr. Avg. -- 2.10 15.60
Return on Equity (TTM) -36.40 1.14 15.99
Return on Equity - 5 Yr. Avg. -- 2.73 16.87
  1 Year 3 Year 5 Year
Sales % -39.52 -8.99 --
EPS (TTM) % -146.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Regenxbio Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 30.93 26.42 89 58
13 Week 66.17 58.08 92 61
26 Week 98.53 83.43 92 78
52 Week 119.08 85.68 90 47
YTD 81.40 59.31 82 59
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 77.29%
# of Holders: 266
Total Shares Held: 27,030,484
3 Mo. Net Change: 419,068
# New Positions: 10
# Closed Positions: 2
# Increased Positions: 32
# Reduced Positions: 13
# Net Buyers: 19
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.